Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease.
about
Multiple cognitive deficits during the transition to Alzheimer's diseaseThe accuracy of 18 FDG-PET in the early diagnosis of Alzheimer’s disease dementia and other dementias in people with MCIConceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative diseaseMild cognitive impairment: pathology and mechanisms.Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ ) deposition11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairmentBiomarkers of Alzheimer's diseaseMild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's DiseaseCharacteristics of Tau and Its Ligands in PET ImagingAutosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical ADMild cognitive impairment and its management in older peopleRole of HIV in amyloid metabolismBrain PET in the diagnosis of Alzheimer's diseaseRole of family history for Alzheimer biomarker abnormalities in the adult children studyQuantitative amyloid imaging using image-derived arterial input functionIdentification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's diseasePET amyloid-beta imaging in preclinical Alzheimer's diseaseThe mismatch negativity as an index of cognitive decline for the early detection of Alzheimer's diseaseCortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease.Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition.Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities.Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studiesBACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions.Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional studyThe multi-functional drug tropisetron binds APP and normalizes cognition in a murine Alzheimer's model.A computational method for computing an Alzheimer's disease progression score; experiments and validation with the ADNI data set.Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain.Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage.Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individualsFibroblast phenotype in male carriers of FMR1 premutation allelesCerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's diseaseMultimodal techniques for diagnosis and prognosis of Alzheimer's diseaseEvidence of neurodegeneration in brains of older adults who do not yet fulfill MCI criteria.Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease.APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.Cerebrospinal fluid biomarkers of Alzheimer's disease.Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease.Evidence for the involvement of apoptosis-inducing factor-mediated caspase-independent neuronal death in Alzheimer diseaseAn expanded role for neuroimaging in the evaluation of memory impairment.
P2860
Q22242620-AFFB5E52-8DD6-418A-9731-88FA942ACDB7Q24201440-02091B5C-3058-4F96-8CAC-914C78A14D61Q24599735-94011C4A-FC77-466B-8E83-EFB7F1E00FD3Q24631255-76379B74-4D54-44FA-9CC1-63E446407038Q24631814-15ED6705-D294-4FC5-9072-7317FF21F3E9Q24648319-0144456E-7CB5-4995-AC7F-8A4324131451Q24650667-F800E90D-627F-47D5-993E-331C7815CBB4Q24678457-96C6140A-C141-4EA5-A151-0FE0CB4A90E4Q26769952-7EEDA339-91C3-4DB6-9532-9330609D3CCCQ26801666-156AD283-CD7C-4805-8ABB-67ED88E9E03BQ26822601-48FB6716-4C79-4758-AE36-E2C1C5DDA4E2Q26824179-6E62F846-70FB-42FC-8AC4-4ECD9446C308Q27011549-009BF88E-3A6B-4C43-8E21-B132C9E2D1CDQ28383467-63DBA30E-EFD9-4F04-9104-CA56B3F21C94Q28545789-1A851C79-6CE9-46D3-B401-B9654C883E46Q28743561-324970A3-C7BB-4016-8542-08C602E30338Q30040695-FF0B4FA6-8C4D-4660-B1DE-4764E6D11505Q30374343-912761E0-880F-4B27-99B6-D7833EEF5C9EQ30436728-9FB90347-63B9-4CF5-98C7-D3282A4A6D77Q30440318-0ACDD903-7902-44BA-8396-DD1148B93926Q30479560-F7696D9F-F1B5-4881-88C7-12C71E056837Q30481978-A00691C6-F09A-4A69-822A-EEEC3E91E964Q30483997-AD56182C-FA4D-4974-8676-FE90D046F2C8Q30529034-577677C9-F09B-43CC-861F-D5B887853901Q30577199-CC8BF185-B5B4-46C0-BEB0-200BA1BB7F05Q30872852-0CB55E1B-C6DA-44E2-8C19-04D477CA51E3Q31047131-215896C9-709E-4427-821C-6261F8B5BD76Q33262303-F817C74B-B6AB-4008-9BC8-A6F7BA5A0592Q33345777-CEF2428C-D452-4EC3-B182-F44D2806E5C4Q33513475-98321F64-51EE-441F-BA95-84169595FE3CQ33552176-30A5D222-15E9-446A-8834-E8DA805FC85EQ33591314-4E3C0642-742F-4A62-A4BB-AFFC62F75FF9Q33607535-D4A30FA2-5FF3-4424-B0E2-2225B0929F49Q33624213-0207CF30-F351-483B-8437-7420C977EBD6Q33687554-9CEB98EA-EDBC-4617-8B05-EA20384EADCEQ33695738-305622F9-2134-4E1F-8865-D272D8BD8AC0Q33757828-140D9B4C-9619-482A-ACB2-8AD21FE7F604Q33759008-EBAEE968-6B3E-457F-9047-935E932A9B00Q33816311-7287D544-C432-4B5B-B73B-76E8B46117B9Q33830698-33E164D4-7E08-4CA5-9C95-52001E468F21
P2860
Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pathologic correlates of nonde ...... rly-stage Alzheimer's disease.
@ast
Pathologic correlates of nonde ...... rly-stage Alzheimer's disease.
@en
Pathologic correlates of nonde ...... rly-stage Alzheimer's disease.
@nl
type
label
Pathologic correlates of nonde ...... rly-stage Alzheimer's disease.
@ast
Pathologic correlates of nonde ...... rly-stage Alzheimer's disease.
@en
Pathologic correlates of nonde ...... rly-stage Alzheimer's disease.
@nl
prefLabel
Pathologic correlates of nonde ...... rly-stage Alzheimer's disease.
@ast
Pathologic correlates of nonde ...... rly-stage Alzheimer's disease.
@en
Pathologic correlates of nonde ...... rly-stage Alzheimer's disease.
@nl
P356
P1476
Pathologic correlates of nonde ...... rly-stage Alzheimer's disease.
@en
P2093
P2888
P304
P356
10.1385/JMN:17:2:101
P577
2001-10-01T00:00:00Z
P6179
1031691219